Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate… Recruiting

2023-503295-25-00 Resectable biliary tract cancers 10 2023-10-31
Safety, pharmacokinetics, and preliminary efficacy of VIR-5500 (AMX-500) in prostate cancer Recruiting

2023-503495-24-00 Hormone-refractory prostate cancer 1 2023-10-30
Expression-linked and R-ISS-adapted stratification for first line therapy in multiple myeloma patients (ELIAS) Recruiting

2022-500453-16-00 Multiple Myeloma 4 2023-10-30
Phase 1/2 Study of Oral Nuvisertib (TP-3654) in Patients with Myelofibrosis Recruiting

2022-502597-16-00 Intermediate or High-risk Primary or Secondary Myelofib 9 2023-10-27
177Lu-edotreotide compared to everolimus in neuroendocrine tumors of the lung and thymus Recruiting

2022-502154-13-00 Patients with well to moderately differentiated neuroen 5 2023-10-27
Clofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study Recruiting

2024-516586-37-00 Urothelial carcinoma 9 2023-10-24
Capsaicin 179 mg patch versus oral Duloxetine in patients with chemotherapy-induced peripheral neuropathy: a phase 3 randomized multicentric… Recruiting

2023-504618-31-00 Chemotherapy induced peripheral neuropathy (CIPN) 5 2023-10-20
A randomized phase II study of gemcitabine versus reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic c… Recruiting

2024-514291-41-00 Pancreatic cancer 4 2023-10-20
Short or long NAT for BR/LAPC (ADVANTAGE) Recruiting

2022-502117-29-00 Advanced pancreatic cancer 5 2023-10-19
Biomarker analysis in patients with metastatic breast cancer treated with sacituzumab govitecan. Recruiting

2023-505385-28-00 male or pre/post-menopausal women age ≥ 18 years with l 4 2023-10-19
A Phase 1/2 Study of the CTPS1 Inhibitor STP938 in Adult Subjects with Relapsed/Refractory B Cell and T-Cell Lymphomas Recruiting

2022-502299-21-00 Relapsed/refractory (R/R) B-cell and T-cell lymphomas 1 2023-10-18
Study evaluating thromboprophylaxis in patients with advanced germ cell tumours of good or intermediate prognosis Recruiting

2022-502426-41-00 Thromboprophylaxis in good and intermediate prognosis a 5 2023-10-17
ROSY-T: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Osimertinib (TAGRISSO) and are Judged by the Investig… Recruiting

2022-501528-58-00 Various tumor types depending on the parent study 5 2023-10-16
Intensified treatment in patients with oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone:… Recruiting

2023-503558-10-00 oligometastatic pancreatic cancer 5 2023-10-13
Testing immunotherapy for patients with liver cancer and moderatelyaltered liver functions Recruiting

2024-516443-57-00 Patients with Hepatocellular Carcinoma (HCC) and Child- 4 2023-10-11
A Modular, Multi-part, Multi-arm, Open-label, Phase I/II Study to Evaluate the Safety and Tolerability of GRWD5769 Alone and in Combination … Recruiting

2023-504845-30-00 Solid malignancies 7 2023-10-05
PARP-PET in solid tumors Recruiting

2022-502918-87-00 cancer patients 3 2023-10-02
Iberdomide Manteinance Versus Lenalidomide Manteinance Therapy Following Autologous Stem Cell Transplant in Participants with NDMM Recruiting

2022-501515-14-00 Newly Diagnosed Multiple Myeloma (NDMM) 5 2023-09-29
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma. Recruiting

2024-514441-11-00 Ewing's sarcoma 4 2023-09-28
A Dose Escalation and Expansion Study of BGB-16673 in Patients with B Cell Malignancies Recruiting

2022-502157-33-00 B-Cell Malignancies 7 2023-09-18
Implementation and evaluation of Pressurized Intrathoracic Aerosol Chemotherapy (PITAC) for the treatment of patients with malignant pleural… Recruiting

2023-503297-20-00 Malignant pleural effusion 3 2023-09-15
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given with Either Cemiplimab, or Cemiplimab + Fianlimab, … Recruiting

2022-501904-83-00 Ovarian Cancer 7 2023-09-11
Circulating microRNAs to choose the IO strategy in PD-L1≥50% NSCLC patients: the Ark clinical trial Recruiting

2022-502253-34-00 non-small cell lung cancer 4 2023-09-11
Phase II, multicenter, randomized, open-label study of premenopausal women with luminal breast cancer investigating the effect of elacestran… Recruiting

2023-503373-37-01 Premenopausal women with early luminal breast cancer 4 2023-09-11